Evidence-Based Medicine
Copyright ©The Author(s) 2023.
World J Clin Cases. Jul 6, 2023; 11(19): 4579-4600
Published online Jul 6, 2023. doi: 10.12998/wjcc.v11.i19.4579
Figure 11
Figure 11  Cluster analysis. A: The 27 active ingredient-disease- targets of after topology analysis; B: The top 10 active ingredient-disease- targets after cytoHubba and MCC tool; C: Identifcation of candidate Polygoni Cuspidati Rhizoma et Radix -related targets for acute lung injury treatment through protein–protein interaction network. 27 candidate targets are finally predicted. BC: Betweenness centrality; CC: Closeness centrality.